Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FCRK7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,752
Award facts
- Contract value 100% obligated
- $49,752.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $49,752.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and was awarded on November 20, 2025. This award carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform all work at its Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, valued at $499,999,999 and effective through December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products to support Department of Defense military healthcare facilities worldwide. The company's demonstrated performance across diverse therapeutic categories, including specialty biologics like Stelara, underscores its critical role within the federal pharmaceutical supply chain serving military medical operations.
Quick answers
Who was awarded contract SPE2DR26FCRK7?
SPE2DR26FCRK7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FCRK7 worth?
The government has obligated $49,752 on SPE2DR26FCRK7.
Is contract SPE2DR26FCRK7 an order under another contract?
Yes. SPE2DR26FCRK7 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRK7 competed?
The extent of competition for SPE2DR26FCRK7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award